AstraZeneca stocks respiratory and cancer pipelines
Thursday, July 31, 2014 - 08:32
in Mathematics & Economics
A $2bn deal with Almirall and a raft of acquisitions and partnership deals bulk up two focus areas for the company
Updated by artificial intelligence Thu, 13 Mar 2025, 3:35:01 UTC Learn more
- Tell your friends
- Get science news via